Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020571

President and CEO sold 5,225 shares at an average $0.36 ($1,906)

  • President and CEO acquired 18,182 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-07 Sale : show line 1 in the form 10b5-1 −2,634 $0.35 $922 436,196 D
2023-07-07 Exercise or conversion : show line 2 in the form 10b5-1 +9,091 445,287 D
2023-07-10 Sale : show line 3 in the form 10b5-1 −2,591 $0.38 $985 442,696 D
2023-07-10 Exercise or conversion : show line 4 in the form 10b5-1 +9,091 451,787 D
Open-market sales · 5,225 sh · avg $0.36 · $1,906

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2023-07-07 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit −9,091 9,091 272,727 D
2023-07-10 Exercise or conversion : show line 6 in the form 10b5-1 Restricted Stock Unit −9,091 9,091 263,636 D
Loading xslF345X04/form4.xml…